Tailored Interventions to Improve Medication Adherence for Cardiovascular Diseases

Over the past half-century, medical research on cardiovascular disease (CVD) has achieved a great deal; however, medication adherence is unsatisfactory. Nearly 50% of patients do not follow prescriptions when taking medications, which limits the ability to maximize their therapeutic effects and resu...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in pharmacology Vol. 11; p. 510339
Main Authors: Xu, Hai-Yan, Yu, Yong-Ju, Zhang, Qian-Hui, Hu, Hou-Yuan, Li, Min
Format: Journal Article
Language:English
Published: Switzerland Frontiers Media S.A 13.11.2020
Subjects:
barriers to medication adherence
cardiovascular disease
medication adherence
medication adherence interventions
Pharmacology
tailored interventions
cardiovascular disease
medication adherence interventions
medication adherence
tailored interventions
barriers to medication adherence
ISSN:1663-9812, 1663-9812
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Over the past half-century, medical research on cardiovascular disease (CVD) has achieved a great deal; however, medication adherence is unsatisfactory. Nearly 50% of patients do not follow prescriptions when taking medications, which limits the ability to maximize their therapeutic effects and results in adverse clinical outcomes and high healthcare costs. Furthermore, the effects of medication adherence interventions are disappointing, and tailored interventions have been proposed as an appropriate way to improve medication adherence. To rethink and reconstruct methods of improving medication adherence for CVD, the literature on tailored interventions for medication adherence focusing on CVD within the last 5 years is retrieved and reviewed. Focusing on identifying nonadherent patients, detecting barriers to medication adherence, delivering clinical interventions, and constructing theories, this article reviews the present state of tailored interventions for medication adherence in CVD and also rethinks the present difficulties and suggests avenues for future development.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Reviewed by: Tanja Mueller, University of Strathclyde, United Kingdom
Edited by: Wil Toenders, ToendersdeGroot B.V., Netherlands
Mark J. C. Nuijten, Ars Accessus Medica (a2m), Netherlands
Specialty section: This article was submitted to Pharmaceutical Medicine and Outcomes Research, a section of the journal Frontiers in Pharmacology
ISSN:1663-9812
1663-9812
DOI:10.3389/fphar.2020.510339